Abstract
We examine the effect of the Undetectables Intervention (UI) on viral loads among socially vulnerable HIV-positive clients. The UI utilized a toolkit that included financial incentives, graphic novels, and community-based case management services. A pre-post repeated measures analysis (n = 502) through 4 years examined longitudinal effects of the intervention. Logistic models regressed social determinants on viral loads. Finally, in-depth qualitative interviews (n = 30) examined how UI shaped adherence. The proportion of virally suppressed time-points increased 15% (from 67 to 82% pre to post-enrollment, p < 0.0001). The proportion of the sample virally suppressed at all time-points increased by 23% (from 39 to 62% pre to post-enrollment, p < 0.0001). African Americans and the homeless were the most likely to be unsuppressed at baseline, but, along with substance users, benefitted the most from UI. The intervention shaped adherence through two pathways, by: (1) establishing worth around adherence, and (2) increasing motivation to become suppressed, and maintain adherence.
Resumen
Examinamos el efecto de la Intervención los Indetectables (II) sobre cargas virales entre clientes de VIH que son socialmente vulnerables. La II utilizo un conjunto de servicios y recursos que incluía incentivos financieros, novelas gráficas, y servicios de manejo de casos basados en la comunidad. Un análisis repetitivo pre y post- (n = 502) sobre cuatro años examino longitudinalmente los efectos de la intervención. Modelos logísticos incluyeron determinantes sociales sobre cargas virales. Finalmente, entrevistas cualitativas a profundidad examinaron como la II afecto adherencia a la medicación. La proporción de puntos en tiempo de cargas virales suprimidas aumento 15% (de 67% preinscripción a 82% postinscripción, p < 0.0001). La proporción de la muestra de cargas virales suprimidas a todos puntos en tiempo aumento por 23% (de 39% preinscripción a 62% postinscripción, p < 0.0001). Afroamericanos y gente sin hogar fueron más probable de no tener cargas virales suprimidas en la línea de base, pero, junto con individuos que usan substancias, fueron los que beneficiaron más de la II. La intervención dio forma a la adherencia a través de dos rutas, por: (1) estableciendo valor a la adherencia, y (2) aumentando motivación para suprimir la carga viral y mantenerse adherente.
Similar content being viewed by others
References
Lundgren JD, Babiker AG, Gordin F, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.
Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316:171–81.
Aidala AA, Wilson MG, Shubert V, et al. Housing status, medical care, and health outcomes among people living with HIV/AIDS: a systematic review. Am J Public Health. 2016;106(1):e1–23.
Feller DJ, Agins BD. Understanding determinants of racial and ethnic disparities in viral load suppression. J Int Assoc Provid AIDS Care. 2017;16(1):23–9.
Palepu A, Milloy MJ, Kerr T, Zhang R, Wood E. Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. J Urban Health. 2011;88(3):545–55.
Feldman MB, Alexy ER, Thomas JA, Gambone GF, Irvine MK. The association between food insufficiency and HIV treatment outcomes in a longitudinal analysis of HIV-infected individuals in New York City. J Acquir Immune Defic Syndr. 2015;69(3):329–37.
Young S, Wheeler AC, McCoy SI, Weiser SD. A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS. AIDS Behav. 2014;8(Suppl 5):S505–15.
Joseph B, Kerr T, Puskas CM, Montaner J, Wood E, Milloy MJ. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting. AIDS Care. 2015;27(9):1128–36.
Small W, Wood E, Betteridge G, Montaner J, Kerr T. The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care. 2009;21(6):708–14.
Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002;16(5):767–74.
Kalichman SC, Kalichman MO, Cherry C. Forget about forgetting: structural barriers and severe non-adherence to antiretroviral therapy. AIDS Care. 2017;29(4):418–22.
Pence BW. The impact of mental health and traumatic life experiences on antiretroviral treatment outcomes for people living with HIV/AIDS. J Antimicrob Chemother. 2009;63(4):636–40.
Whetten K, Reif S, Whetten R, Murphy-McMillan LK. Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. Psychosom Med. 2008;70(5):531–8.
Robbins GK, Daniels B, Zheng H, et al. Predictors of antiretroviral treatment failure in an urban HIV clinic. J Acquir Immune Defic Syndr. 2007;44(1):30–7.
Weiser SD, Hatcher A, Frongillo EA, et al. Food insecurity is associated with greater acute care utilization among HIV-infected homeless and marginally housed individuals in San Francisco. J Gen Intern Med. 2012;28(1):91–8.
Pence BW, Miller WC, Gaynes BN, Eron JJ Jr. Psychiatric illness and virologic response in patients initiating Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2007;44(2):159–66.
Auerbach JD, Parkhurst JO, Cáceres CF. Addressing social drivers of HIV/AIDS for the long-term response: conceptual and methodological considerations. Glob Public Health. 2011;6(Suppl 3):S293–309.
Adimora AA, Auerbach JD. Structural interventions for HIV prevention in the United States. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S132–5.
Brown JL, Vanable PA. Cognitive-behavioral stress management interventions for persons living with HIV: a review and critique of the literature. Ann Behav Med. 2008;35(1):26–40.
Olem D, Sharp KM, Taylor JM, Johnson MO. Overcoming barriers to HIV treatment adherence: a brief cognitive behavioral intervention for HIV-positive adults on antiretroviral treatment. Cogn Behav Pract. 2014;21(2):206–23.
Safren SA, O’Cleirigh CM, Bullis JR, Otto MW, Stein MD, Pollack MH. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80(3):404–15.
Gwadz M, Cleland CM, Applegate E, et al. Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention. AIDS Behav. 2015;19(10):1801–17.
Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: a randomized controlled trial. J Aquir Immune Defic Syndr. 2007;46(4):443–50.
Brennan-Ing M, Seidel L, Rodgers L, et al. The impact of comprehensive case management on HIV client outcomes. PLoS ONE. 2016;11(2):e0148865.
Kushel MB, Colfax G, Ragland K, Heineman A, Palacio H, Bangsberg DR. Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. Clin Infect Dis. 2006;43(2):234–42.
Irvine MK, Chamberlin SA, Robbins RS, et al. Improvements in HIV Care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination program. Clin Infect Dis. 2015;60:298–310.
Macalino GE, Hogan JW, Mitty JA, et al. A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS. 2007;21(11):1473–7.
de Lima IC, Galvão MTG, de Oliveira Alexandre H, Lima FET, de Araújo TL. Information and communication technologies for adherence to antiretroviral treatment in adults with HIV/AIDS. Int J Med Inform. 2016;92:54–61.
Petersen ML, Wang Y, van der Laan MJ, Guzman D, Riley E, Bangsberg DR. Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis. 2007;45(7):908–15.
Deering KN, Shannon K, Sinclair H, Parsad D, Gilbert E, Tyndall MW. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDS. 2009;23(8):603–9.
Sutherland K, Christianson JB, Leatherman S. Impact of targeted financial incentives on personal health behavior: a review of the literature. Med Care Res Rev. 2008;65(6 Suppl):36S–78S.
Petry NM, Rash CJ, Byrne S, Ashraf S, White WB. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012;125(9):888–96.
Taylor NK, Buttenheim AM. Improving utilization of and retention in PMTCT services: can behavioral economics help? BMC Health Serv Res. 2013;13:406.
Adamson B, El-Sadr W, Dimitrov D, et al. The cost-effectiveness of financial incentives for viral suppression: HPTN 065 Study. Value Health. 2019;22(2):194–202.
Bassett IV, Wilson D, Taaffe J, Freedberg KA. Financial incentives to improve progression through the HIV treatment cascade. Curr Opin HIV AIDS. 2015;10(6):451–63.
DeFulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med. 2012;55(Suppl):S86–94.
El-Sadr WM, Donnell D, Beauchamp G, et al. Financial incentives for linkage to care and viral suppression among HIV-positive patients: a randomized clinical trial (HPTN 065). JAMA Intern Med. 2017;177(8):1083–92.
Metsch LR, Feaster DJ, Gooden L, et al. Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a randomized clinical trial. JAMA. 2016;316(2):156–70.
Farber S, Tate J, Frank C, et al. A study of financial incentives to reduce plasma HIV RNA among patients in care. AIDS Behav. 2013;17(7):2293–300.
Author. The effects of financial incentives on viral load suppression among homeless people with HIV. International AIDS Conference, Durban South Africa (2016)
Author. The Undetectables intervention at Housing Works. Report submitted to the Robin Hood Foundation, New York City, pp. 1–25 (2017).
Montano DE, Kasprzyk D. Theory of reasoned action, theory of planned behavior, and the integrated behavior model. In: Glanz K, Rimer BK, Vishwanath K, editors. Health behavior and health education. San Francisco: Jossey-Bas; 2008. p. 67–96.
Housing Works. The Undetectables Intervention: Read the comics. https://liveundetectable.org/comics. Accessed Dec 10, 2018.
Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18:59–82.
Cole SR, Napravnik Mugavero MJ, Lau B, Eron JJ Jr, Saag MS. Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden. Am J Epidemiol. 2010;71(2):198–205.
NVivo Qualitative Data Analysis Software. QSR International Pty Ltd. Version 10, 2012.
Bowen GA. Grounded theory and sensitizing concepts. Int J Qual Methods. 2006;5(3):12–23.
Padgett DK. Coming of age: theoretical thinking, social responsibility, and a global perspective in qualitative research. In: Padgett DK, editor. The qualitative research experience. Belmont: Wadsworth/Thomson Learning; 2004. p. 297–315.
Campbell JL, Quicy C, Osserman J. Coding in-depth semi-structured interviews: problems of unitization and intercoder reliability and agreement. Sociol Methods Res. 2013;42(3):294–320.
Krippendorff K. Content analysis: an introduction to its methodology. 2nd ed. Thousand Oaks: Sage; 2004. p. 2004.
Acknowledgements
We thank the Robin Hood Foundation for funding this study. We thank Housing Works for supporting the intervention and this study. We also thank Farnaz Malik, Michelle Davidson, and Paige Andrews for providing support for the study.
Funding
This study was funded by a Robin Hood Foundation Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Toorjo Ghose declares that he has no conflict of interest. Virginia Shubert declares that she has no conflict of interest. Vaty Poitevien declares that she has no conflict of interest. Sambuddha Choudhuri declares that he has no conflict of interest. Robert Gross declares that he has no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ghose, T., Shubert, V., Poitevien, V. et al. Effectiveness of a Viral Load Suppression Intervention for Highly Vulnerable People Living with HIV. AIDS Behav 23, 2443–2452 (2019). https://doi.org/10.1007/s10461-019-02509-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-019-02509-5